Lipopolysaccharide evokes the modulation of brain cytochrome P4501A in the rat

Brain Research

Volumn 842, Issue 1, 1999, Pages 139-147

  Renton, Kenneth W ^a   Dibb, Sandra ^a   Levatte, Terry L ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Central nervous system inflammation; Cytochrome P450; Lipopolysaccharide

Indexed keywords

ETHOXYRESORUFIN DEETHYLASE; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ARTICLE; ENCEPHALITIS; ENZYME ACTIVATION; ENZYME ACTIVITY; HIPPOCAMPUS; MALE; MULTIGENE FAMILY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BRAIN; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; ENDOTOXINS; ESCHERICHIA COLI; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENTRICULAR; LATERAL VENTRICLES; LIPOPOLYSACCHARIDES; MALE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0033581335     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01773-4     Document Type: Article

References (68)

1. Anandatheerthavarada H.K., Williams J.F., Wecker L. The chronic administration of nicotine induces cytochrome P450 in rat brain. J. Neurochem. 60:1993;1941-1944.
2. Arvin B., Neville L.F., Barone F.C., Feurstein G.Z. Brain injury and inflammation, a putative role for TNF-alpha. Ann. N.Y. Acad. Sci. 116:1995;62-71.
3. Barker C.W., Fagan J.B., Pasco D.S. Interleukin-1 beta suppresses the induction of P4501A1 and P4501A2 mRNAs in isolated hepatocytes. J. Biol. Chem. 267:1992;8050-8055.
4. Bergh A.F., Strobel H.W. Reconstitution of the brain mixed function oxidase system: purification of NADPH-cytochrome P450 reductase and partial purification of cytochrome P450 from whole rat brain. J. Neurochem. 59:1992;575-581.
5. Beyaert R., Cuenda A., vanden Berghe W., Plaisance S., Lee J.C., Haegeman G., Cohen P., Fiers W. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO Journal. 15:1996;1914-1923.
6. Bhagwat S.V., Boyd M.R., Ravindranath V. Rat brain cytochrome P450: reassessment of monooxygenase activities and cytochrome P450 levels. Drug Metab. Dispos. 23:1995;651-654.
7. Bruce A., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., Mattson M.P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injusr in mice lacking TNF receptors. Nature Medicine. 2:1996;788-794.
8. Burke M.D., Thompson S., Elcombe C.R., Halpert J., Haaparanta T., Mayer R.T. Ethoxy, pentoxy and benzyloxyphenoxazones and homologues; a series of substances of substrates to distinguish between different induced cytochromes P450. Biochem. Pharmacol. 34:1985;3337-3345.
9. Carlson T.J., Billings R.E. Role of nitric oxide in the cytokine-mediated regulation of cytochrome P-450. Mol. Pharmacol. 49:1996;796-801.
10. Chang K.C., Lauer B.A., Bell T.D., Chai H. Altered theophylline pharmacokinetics during acute rispiratory viral illness. Lancet. 1:1978;1132-1133.
11. Clark M.A., Bing B.A., Gottschall P.E., Williams J.F. Differential effect of cytokines on the phenobarbital or 3-methylcholanthrene induction of P450 mediated monooxygenase activity in cultured rat hepatocytes. Biochem. Pharmacol. 49:1995;97-104.
12. Clarke C.J., Boyd G. Theophylline pharmacokinetics during respiratory viral infection. Lancet. 1:1979;492.
13. Craig P.I., Mehta I., Murray M., McDonald D., Astrom A.H.v.d.M.P., Farrell G.C. Interferon down regulates the male-specific cytochrome P450IIIA2 in rat liver. Mol. Pharmacol. 38:1990;313-318.
14. Craig P.I., Murray M., Farrell G.C. Interferon suppresses the isoform-specific activities of hepatic cytochrome P450 in female rats. Biochem. Pharmacol. 43:1992;908-910.
15. Cribb A.E., Delaporte E., Kim S.G., Novak R.F., Renton K.W. Regulation of cytochrome P-4501A and cytochrome P-4502E induction in the rat. J. Pharmacol. Exp. Ther. 268:1994;487-494.
16. Delaporte E., Cribb A.E., Renton K.W. Interferon-mediated changes in the expression of CYP1A1 in human B lymphoblastoid (AHH-1 TK±) cells. Can. J. Physiol. Pharmacol. 73:1995;1692-1697.
17. Delaporte E., Cribb A.E., Renton K.W. Modulation of rat hepatic CYP3A1 induction by the interferon inducer polyinosinic acid-polycytidylic acid, polyic. Drug Metab. Dispos. 21:1993;520-523.
18. Fleetham J.A., Nakatsu K., Munt P.W. Theophylline pharmacokinetics and respiratory infections. Lancet. 2:1978;898.
19. Fukada Y., Sassa S. Suppression of cytochrome P-4501A1 by interleukin-6 in human hepaG2 hepatoma cells. Biochem. Pharmacol. 47:1994;1187-1195.
20. Fukuda Y., Ishida N., Noguchi T., Kappas A., Sassa S. Interleukin-6 down regulates the expression of transcripts encoding cytochrome P450 1A1, 1A2 and III3A in human hepatoma cells. Biochem. Biophys. Res. Commun. 184:1992;960-965.
21. Garcion E., Sindji L., Montero-Menei C., Andre C., Brachet P., Darcy F. Expression of inducible nitric oxide synthase during rat brain inflammation. Glia. 22:1998;282-294.
22. Gayle D., Ilyin S., Flynn M.C., Plata-Salaman C.R. Lipopolysaccharide and muramyl dipeptide induced anorexia during refeeding following acute fasting: characterization of brain cytokine and neuropeptide systems mRNA. Brain Res. 795:1998;77-86.
23. Ghirnikar R.S., Lee Y.L., Eng L.F. Inflammation in traumatic brain injury: role of cytokines and chemokines. Neurochem. Res. 23:1998;329-340.
24. Glovinski J., Iverson L.L. Regional studies of catecholamines in the rat brain-1 the disposition of 3H-dopamine and 3H-DOPA in various regions of the brain. J. Neurochem. 13:1966;655-669.
25. Greenwald M., Koren G. Viral induced changes in theophylline handling in children. Am. J. Asthma Allergy Pediatr. 3:1990;162.
26. Hadasová E., Franke G., Zschiesche M., Cesková E., Zelenková O., Siegmund W. Debrisoquine 4-hydroxylation and sulphamethazine N-acetylation in patients with schizophrenia and major depression. Br. J. Clin. Pharmacol. 41:1996;428-431.
27. Hauser G.J., Dayao E.K., Wasserloos K., Pitt B.R., Wong H.R. HSP induction inhibits iNOS mRNA expression and attenuates hypotension in endotoxin-challenged rats. American Journal of Physiology. 271:1996;H2529-H2535.
28. Hauss-Wegrzyniak B., Dobrzanski P., Stoehr J.D., Wenk G.L. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res. 780:1998;294-303.
29. Hauss-Wegrzyniak B., Lukovic L., Bigaud M., Stoeckel M.E. Brain inflammatory response induced by intracerebroventricular infusion of lipopolysaccharide: an immunohistochemical study. Brain Res. 794:1998;211-224.
30. Kapitulink J., Gelboin H.V., Guengerich F.P., Jacobowitz D.M. Immunochemical localization of cytochrome P450 in rat brain. Neuroscience. 20:1987;829-833.
31. Kawashima H., Kusunose E., Thompson C.M., Strobel H.W. Protein expression, characterization, and regulation of CYP4F4 and CYP4F5 cloned from rat brain. Arch. Biochem. Biophys. 347:1997;148-154.
32. Kawashima H., Strobel H.W. cDNA cloning of a novel rat brain cytochrome P450 belonging to the CYP2d subfamily. Biochem. Biophys. Res. Commun. 209:1995;535-540.
33. Kempermann G., Knoth R., Gebicke-Haerter P.J., Stolz B.-J., Volk B. Cytochrome P450 in rat astrocytes in vivo and in vitro: intracellular localization and induction by phenytoin. J. Neurosci. Res. 39:1994;576-588.
34. Kraemer M.J., Furukawa C., Koup J.P., Shapiro G. Altered theophylline clearance during an influenza outbreak. Pediatrics. 69:1982;476-480.
35. Lassmann H. Basic mechanisms of brain inflammation. J. Neural Transm. 104:1997;183-190.
36. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
37. McFadyen M.C.E., Melvin W.T., Murray G.I. Cytochrome P450 in normal human brain and brain tumours. Biochem. Soc. Trans. 25:1997;S577-S577.
38. Monshouwer M., McLellan R.A., Delaporte E., Witkamp R.F., van Miert A.S., Renton K.W. Differential effect of pentoxifylline on lipopolysaccharide-induced downregulation of cytochrome P450. Biochem. Pharmacol. 52:1996;1195-1200.
39. Monshouwer M., Witkamp R.F., Nijmeijer S.M., van Leengoed L.A., Vernooy H.C., Verheijden J.H., van Miert A.S. A lipopolysaccharide-induced acute phase response in the pig is associated with a decrease in hepatic cytochrome P450-mediated drug metabolism. J. Vet. Pharmacol. Ther. 19:1996;382-388.
40. Morgan E.T. Suppression of P450IIC12 gene expression and elevation of actin messenger. Biochem. Pharmacol. 42:1991;51-57.
41. Morgan E.T., Norman C.A. Pretranslational suppression of cytochrome P-450h (IIC11) gene expression. Drug Metab. Dispos. 18:1990;649-653.
42. Morse D.C., Stein A.P., Thomas P.E., Lowndes H.E. Distribution and induction of cytochrome P450 1A1 and 1A2 in rat brain. Toxicol. Appl. Pharmacol. 152:1998;232-239.
43. Nelson D.R., Koymans L., Kamataki T., Stegman J.J., Feyereisen R., Waxman D.J., Waterman M.R., Gotoh O., Coon M.J., Estabrook R.W., Gunsalus I.C., Nebert D.W. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics. 6:1996;1-42.
44. T.E. Nicholson, K.W. Renton, Modulation of cytochrome P450 by inflammation in astrocytes, Brain Res., in press, 1999.
45. Norris P.J., Hardwick J.P., Emson P.C. Regional distribution of cytochrome P450 2D1 in the rat central nervous system. J. Comp. Neurol. 366:1996;244-258.
46. Okuno H., Shiozaki Y., Kiato Y., Kuneida K., Seki T., Sameshima Y. Depression of drug metabololizing activity in human liver by interferon-a. Eur. J. Clin. Pharmacol. 39:1990;365-367.
47. Padmashtree S., Bhamre S., Upadhya S.C., Boyd M.R., Ravindranath V. Expression of multiple forms of cytochrome P450 and associated mono-oxygenase activities in rat brain regions. Biochem. Pharmacol. 56:1998;371-375.
48. Perry V.H., Andersson B., Gordon S. Macrophages and inflammation in the central nervous system. Trends Neurosci. 16:1993;268-273.
49. Ravindranath V. Metabolism of xenobiotics in the central nervous system - Implications and challenges. Biochem. Pharmacol. 56:1998;547-551.
50. Ravindranath V., Boyd M.R. Xenobiotic metabolism in brain. Drug Metab. Rev. 27:1995;419-448.
51. K.W. Renton, Relationships between the enzymes of detoxication and host defence mechanisms, in: J. Caldwell, W.B. Jacoby (Eds.), Biological Basis of Detoxication, Academic Press, New York, 1983, pp. 307-324.
52. Renton K.W., Knickle L.C. Regulation of hepatic cytochrome P-450 during infectious disease. Can. J. Physiol. Pharmacol. 68:1990;777-781.
53. Rothwell N.J., Luheshi G., Toulland S. Cytokines and their receptors in the central nervous system: physiology, pharmacology and pathology. Pharmacol. Ther. 69:1996;85-95.
54. Sakai H., Okamoto T., Kikkawa Y. Suppression of hepatic drug metabolism by the interferon inducer. J. Pharmacol. Exp. Ther. 263:1992;381-386.
55. Sanne J.L., Krueger K.E. Expression of cytochrome P450 side-chain cleavage enzyme and 3 beta-hydroxysteroid dehydrogenase in the rat central nervous system: a study by polymerase chain reaction and in situ hybridization. J. Neurochem. 65:1995;528-536.
56. Schilter B., Omiecinski C.J. Regional distribution and expression modulation of cytochrome P450 and epoxide hydrolase mRNAs in the rat brain. Mol. Pharmacol. 44:1993.
57. Sewer M.B., Barclay T.B., Morgan E.T. Down-regulation of cytochrome p450 mRNAs and proteins in mice lacking a functional NOS2 gene. Mol. Pharmacol. 54:1998;273-279.
58. Stanley L.A., Adams D.J., Balkwill F.R., Griffin D., Wolf C.R. Differential effects of recombinant interferon alpha on constitutive and. Biochem. Pharmacol. 42:1991;311-320.
59. H.W. Strobel, H. Kawashima, J. Geng, D. Sequeira, A. Bergh, A.V. Hodgson, H. Wang, S. Shen, Expression of multiple forms of brain cytochrome P450, 1995.
60. Tinberg N., Ingelman-Sundberg M. Expression, catalytic activity, and inducibility of cytochrome P450 2E1 (CYP2E1) in the rat central nervous system. J. Neurochem. 67:1996;2066-2073.
61. Tindberg N., Baldwin H.A., Cross A.J., Ingelman Sundberg M. Induction of cytochrome P450 2E1 expression in rat and gerbil astrocytes by inflammatory factors and ischemic injury. Mol. Pharmacol. 50:1996;1065-1072.
62. Tinel M., Robin M.A., Doostzadeh J., Maratrat M., Ballet F., Fardel N., El Kahwaji J., Beaune P., Daujat M., Labbe G., Pessayre D. The interleukin-2 receptor down-regulates the expression of cytochrome P450 in cultured rat hepatocytes. Gastroenterology. 109:1995;1589-1599.
63. B. Volk, R.P. Meyer, L.F. Von, B. Ibach, R. Knoth, Localization and characterization of cytochrome P450 in the brain. In vivo and in vitro investigations on phenytoin- and phenobarbital-inducible isoforms, 1995.
64. Warner M., Gustafsson J.A. Effect of ethanol on cytochrome P450 in the rat brain. Proc. Natl. Acad. Sci. U.S.A. 91:1994;1019-1023.
65. Warner M., Stromstedt M., Wyss A., Gustafsson J.A. Regulation of cytochrome P450 in the central nervous system. J. Steroid Biochem. Mol. Biol. 47:1993;191-194.
66. Williams S.J., Farrell G.C. Inhibition of antipyrine metabolism by interferon. Br. J. Clin. Pharmacol. 22:1986;610-612.
67. Wright K., Morgan E.T. Transcriptional and post-transcriptional supression of P450IIC11 and P450IIC12 by inflammation. FEBS Lett. 271:1990;59-61.
68. Wyss A., Gustafsson J.A., Warner M. Cytochromes P450 of the 2D subfamily in rat brain. Mol. Pharmacol. 47:1995;1148-1155.